130 related articles for article (PubMed ID: 32686139)
1. Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia.
Paul S; Jammal N; Akhave N; Aung PP; Loghavi S; Jain N; Garcia-Manero G; Borthakur G; Verstovsek S; Jabbour E; Adachi J; Masarova L; Daver N; Ravandi F; Pemmaraju N
Br J Haematol; 2020 Oct; 191(1):e10-e13. PubMed ID: 32686139
[No Abstract] [Full Text] [Related]
2. Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients.
Sujobert P; Cuccuini W; Vignon-Pennamen D; Martin-Garcia N; Albertini AF; Uzunov M; Redjoul R; Dombret H; Raffoux E
J Invest Dermatol; 2013 Apr; 133(4):1111-4. PubMed ID: 23190893
[No Abstract] [Full Text] [Related]
3. Giant cellulitis-like Sweet syndrome as an initial clinical presentation of acute myeloblastic leukemia with t(6;9)(p23;q34): DEK-CAN and internal duplications of FMS-like tyrosine kinase 3.
Okuyama S; Nito T; Yanagawa N; Tajima K
Ann Hematol; 2019 Mar; 98(3):787-788. PubMed ID: 30659317
[No Abstract] [Full Text] [Related]
4. Histiocytoid Sweet syndrome harboring an isocitrate dehydrogenase 1 mutation: A case report and retrospective analysis of 29 cases of histiocytoid Sweet syndrome.
Libby TJ; Fleming K; Amin B
J Cutan Pathol; 2019 Apr; 46(4):290-292. PubMed ID: 30632174
[TBL] [Abstract][Full Text] [Related]
5. Highly atypical myeloblasts in acute myeloid leukaemia with myelodysplasia-related changes in a patient with short telomere syndrome.
Li Y; Dorfman DM
Br J Haematol; 2018 Nov; 183(4):536. PubMed ID: 30043450
[No Abstract] [Full Text] [Related]
6. Clinicopathologic, immunophenotyping and cytogenetic analysis of Sweet syndrome in Egyptian patients with acute myeloid leukemia.
El-Khalawany M; Aboeldahab S; Mosbeh AS; Thabet A
Pathol Res Pract; 2017 Feb; 213(2):143-153. PubMed ID: 28024959
[TBL] [Abstract][Full Text] [Related]
7. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
Nakase K; Kita K; Kyo T; Katayama N
Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
[No Abstract] [Full Text] [Related]
8. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
9. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease.
Magro CM; Kiani B; Li J; Crowson AN
J Cutan Pathol; 2007 Jul; 34(7):526-34. PubMed ID: 17576331
[TBL] [Abstract][Full Text] [Related]
10. 20q- clonality in a case of oral sweet syndrome and myelodysplasia.
Van Loon K; Gill RM; McMahon P; Chigurupati R; Siddiqi I; Fox L; Damon L; McCalmont TH; Jordan R; Wolf J
Am J Clin Pathol; 2012 Feb; 137(2):310-5. PubMed ID: 22261459
[TBL] [Abstract][Full Text] [Related]
11. Structural chromosomal abnormality of 1q in acute leukemia with Sweet syndrome.
Colovic M; Jankovic G; Suvajdzic N; Nikolic M
Cancer Genet Cytogenet; 2002 Nov; 139(1):84-5. PubMed ID: 12547167
[No Abstract] [Full Text] [Related]
12. [Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia].
Gritsaev SV; Kostroma II; Zapreev IM; Shmidt AV; Tiranova SA; Balashova VA; Martynkevich IS; Chubukina ZV; Semenova NY; Chechetkin AV
Ter Arkh; 2016; 88(7):104-108. PubMed ID: 27459623
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet's Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils.
Passet M; Lepelletier C; Vignon-Pennamen MD; Chasset F; Hirsch P; Battistella M; Duriez P; Sicre de Fontbrune F; Boissel N; Legrand O; Raffoux E; Bagot M; Adès L; Clappier E; Bouaziz JD
J Invest Dermatol; 2020 Sep; 140(9):1873-1876.e5. PubMed ID: 32081610
[No Abstract] [Full Text] [Related]
14. Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia.
Zhang X; Guo X
Ann Hematol; 2019 Sep; 98(9):2223-2225. PubMed ID: 30980106
[No Abstract] [Full Text] [Related]
15. Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.
Huang H; Qin T; Xu Z; Shi Z; Li B; Pan L; Hu N; Qu S; Huang G; Gale RP; Xiao Z
Br J Haematol; 2020 Mar; 188(5):796-800. PubMed ID: 31880320
[No Abstract] [Full Text] [Related]
16. JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid leukaemia.
Wang HY; Dell'Aquila ML; Dvanajscak Z; Bejar R; Broome HE; Hsi E; Murray SS; Thorson JA
Br J Haematol; 2019 May; 185(3):566-570. PubMed ID: 30132795
[No Abstract] [Full Text] [Related]
17. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.
Ohanian M; Bueso-Ramos C; Ok CY; Lin P; Patel K; Alattar ML; Khoury JD; Rozovski U; Estrov Z; Huh YO; Cortes J; Abruzzo LV
Cancer Genet; 2015 Nov; 208(11):571-4. PubMed ID: 26382622
[TBL] [Abstract][Full Text] [Related]
18. Structural chromosomal abnormalities of 3q in myelodysplastic syndrome/acute myeloid leukaemia with Sweet's syndrome.
Billström R; Heim S; Kristoffersson U; Mandahl N; Mitelman F
Eur J Haematol; 1990 Sep; 45(3):150-2. PubMed ID: 2226727
[TBL] [Abstract][Full Text] [Related]
19. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract][Full Text] [Related]
20. Sweet syndrome-like neutrophilic infiltrate as initial presentation of acute myelogenous leukemia.
Travassos AR; Soares-de-Almeida L; Kutzner H; Guerra L; Alves do Carmo J; Filipe P; Marques MS
Am J Dermatopathol; 2014 Oct; 36(10):e167-70. PubMed ID: 23538898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
